Target DNA mutagenesis-based fluorescence assessment of off-target activity of the CRISPR-Cas9 system

Dan Wang1, Cuili Niu1, Jingxin Han1

  • 1Department of Chemical Biology, State Key Laboratory of Elemento-Organic Chemistry, National Engineering Research Center of Pesticide (Tianjin), College of Chemistry, Nankai University Tianjin 300071 China zhenxi@nankai.edu.cn.

RSC Advances
|May 6, 2022
PubMed

Insights

CRISPR/Cas9 genome editing can cause unintended mutations. A new fluorescence assay detects Cas9 activity at off-target sites, revealing low tolerance for mismatches near PAM sites, improving genome engineering safety.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biotechnology

Background:

  • The CRISPR/Cas9 system enables precise DNA cleavage but can cause off-target mutations.
  • Understanding sgRNA-DNA interactions at off-target sites is crucial for safety.
  • A direct cell-based assay for detecting Cas9 activity at off-target sites was lacking.

Purpose of the Study:

  • To develop a rapid, cell-based fluorescence assay for detecting Cas9 activity at off-target DNA sites.
  • To investigate the impact of nucleotide mismatches on Cas9 binding and activity.
  • To evaluate the specificity of Cas9 nucleases and high-fidelity variants.

Main Methods:

  • Development of a target DNA mutagenesis-based fluorescence assay.
  • Direct detection of Cas9 nuclease activity in living cells.
  • Assessment of Cas9 tolerance to nucleotide mismatches near PAM sites.

Main Results:

  • Cas9 nuclease exhibits low tolerance to nucleotide mismatches in the binding region adjacent to PAM sites.
  • A trade-off between Cas9 activity and specificity was observed.
  • Comparison with a high-fidelity Cas9 variant highlighted specificity differences.

Conclusions:

  • The developed fluorescence assay enables direct detection of Cas9 off-target activity in cells.
  • Understanding mismatch tolerance is key to minimizing off-target mutations.
  • Combining computational predictions with this assay can guide safer genome engineering strategies.

Related Concept Videos

CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
53.1K
Homologous Recombination02:31

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
53.4K
CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
466